I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in..:
DuBois, Steven G
;
Marachelian, Araz
;
Fox, Elizabeth
...
qt2b07g549. , 2016
Link:
https://escholarship.org/uc/item/2b07g549
RT Journal T1
Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt2b07g549&Exemplar=1&LAN=DE A1 DuBois, Steven G A1 Marachelian, Araz A1 Fox, Elizabeth A1 Kudgus, Rachel A A1 Reid, Joel M A1 Groshen, Susan A1 Malvar, Jemily A1 Bagatell, Rochelle A1 Wagner, Lars A1 Maris, John M A1 Hawkins, Randall A1 Courtier, Jesse A1 Lai, Hollie A1 Goodarzian, Fariba A1 Shimada, Hiroyuki A1 Czarnecki, Scarlett A1 Tsao-Wei, Denice A1 Matthay, Katherine K A1 Mosse, Yael P PB eScholarship, University of California YR 2016 K1 Biomedical and Clinical Sciences K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Hematology K1 Orphan Drug K1 Clinical Trials and Supportive Activities K1 Pediatric Cancer K1 Rare Diseases K1 Neurosciences K1 Neuroblastoma K1 Pediatric K1 Clinical Research K1 Cancer K1 6.1 Pharmaceuticals K1 Evaluation of treatments and therapeutic interventions K1 Administration K1 Oral K1 Adolescent K1 Adult K1 Antineoplastic Combined Chemotherapy Protocols K1 Aurora Kinase A K1 Azepines K1 Camptothecin K1 Child K1 Preschool K1 Dacarbazine K1 Disease Progression K1 Disease-Free Survival K1 Drug Administration Schedule K1 Drug Resistance K1 Neoplasm K1 Female K1 Genotype K1 Glucuronosyltransferase K1 Humans K1 Infant K1 Irinotecan K1 Kaplan-Meier Estimate K1 Male K1 Maximum Tolerated Dose K1 Neoplasm Recurrence K1 Local K1 Phenotype K1 Protein Kinase Inhibitors K1 Pyrimidines K1 Tablets K1 Temozolomide K1 Time Factors K1 Treatment Outcome JF qt2b07g549 LK http://dx.doi.org/https://escholarship.org/uc/item/2b07g549 DO https://escholarship.org/uc/item/2b07g549 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)